Clinical trial
A Double-Blind, Placebo-Controlled, Multicenter Study To Examine the Effects of Finasteride 1 MG on Serum Prostate-Specific Antigen in Men With Androgenetic Alopecia
NCT00396175 is registered in ClinicalTrials.gov with Organon and Co as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Double-Blind, Placebo-Controlled, Multicenter Study To Examine the Effects of Finasteride 1 MG on Serum Prostate-Specific Antigen in Men With Androgenetic Alopecia
- Lead sponsor
- Organon and Co
- Phase
- Phase 3
- Overall status
- Completed
- Start date
- March 31, 1998
- Completion date
- Not reported
- Enrollment
- 355
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.
androgenetic alopecia